title: Antimycobacterial activity of ferutinin alone and in combination with antitubercular drugs against a rapidly growing surrogate of Mycobacterium tuberculosis.
abstract: The aim of this study was to investigate the antimycobacterial activity of the major daucane constituent, ferutinin (jaeschkeandiol p-hydroxybenzoate, 1), four of its natural analogues, its hydrolysis products, as well as methyl p-hydroxybenzoate (methylparaben) against Mycobacterium smegmatis, a rapidly growing surrogate of Mycobacterium tuberculosis. The agar dilution assay was utilised for an antimycobacterial evaluation of single compounds. A modified agar dilution assay, the checkerboard method, was utilised for evaluating the potentiating effect of 1 on different antitubercular drugs, namely isoniazid, ethionamide, rifampin and streptomycin. In the agar dilution assay, 1 exhibited higher potency (minimum inhibitory concentration [MIC] 10 µg mL⁻¹) than streptomycin and rifampin (MIC 20 µg mL⁻¹ for each). Of the natural analogues, 8,9-epoxyjaeschkeandiol p-hydroxybenzoate and 8,9-epoxyjaeschkeandiol benzoate exhibited marginal activity (MIC ≥ 40 and 80 µg mL⁻¹, respectively). The checkerboard method showed that the combination of 1 with each antitubercular drug led to mutual enhancement of the antimycobacterial activity with isoniazid and ethionamide, while no such effect was observed with rifampin or streptomycin. Based on this study and earlier studies with Staphylococcus aureus, the major constituent 1 may be responsible for the major part of the antimicrobial activity of the root of Ferula hermonis.
authors: College of Pharmacy, Chicago State University, 9501 South King Drive, Chicago, IL 60628, USA. eabouras@csu.edu
authors: Ehab A
authors: EA
authors: Abourashed
authors: Ahmed M
authors: AM
authors: Galal
authors: Atef M
authors: AM
authors: Shibl
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000904:Antibiotics, Antitubercular / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology*; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology; D003508:Cycloheptanes / Q000494:pharmacology*; D005000:Ethionamide / Q000494:pharmacology; D005309:Ferula / Q000737:chemistry*; D007538:Isoniazid / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010226:Parabens / Q000494:pharmacology; D018517:Plant Roots / Q000737:chemistry*; D012293:Rifampin / Q000494:pharmacology; D012717:Sesquiterpenes / Q000494:pharmacology*; D013307:Streptomycin / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001565:Benzoates; D001643:Bridged Bicyclo Compounds; D003508:Cycloheptanes; D010226:Parabens; D012717:Sesquiterpenes; C111068:4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en; C015358:methylparaben; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin